Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics
Published inAmerican Heart Journal, vol. 220, p. 203-212
Publication date2020
Abstract
Affiliation
Research group
Citation (ISO format)
BOCCARA, Franck et al. Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics. In: American Heart Journal, 2020, vol. 220, p. 203–212. doi: 10.1016/j.ahj.2019.11.004
Main files (1)
Article (Published version)
Identifiers
- PID : unige:153246
- DOI : 10.1016/j.ahj.2019.11.004
- PMID : 31841795
ISSN of the journal0002-8703